Solas BioVentures

Stimdia Medical develops a non-invasive lung pacing device that reduces the time required to get a patient off a ventilator, resulting in significant cost savings.

Pathware Inc. is a company that manufactures automated point-of-care biopsy assessment systems, primarily through its product Bioptic. This system enables clinicians and technicians to diagnose pathogens and provides a complete slide imaging and sample management platform designed to enhance pathology workflows. By simplifying the process and reducing repetition, Pathware aims to improve the efficiency of pathologists while maintaining high standards of care. Established in 2017 and headquartered in Ann Arbor, Michigan, with a second location in Seattle, Washington, Pathware was formerly known as MedKairos, Inc. The company is committed to developing intuitive hardware and software solutions that facilitate critical diagnostic processes.

CryOSA, Inc., a medical device company, develops novel treatments for patients with sleep disordered breathing. It offers therapies for obstructive sleep apnea. CryOSA, Inc. was incorporated in 2014 and is based in Roseville, Minnesota.

Francis Medical, Inc. is a medical technology company based in Maple Grove, Minnesota, founded in 2018. The company specializes in developing vapor ablation therapy devices aimed at treating various urological cancers, including prostate, kidney, and bladder cancers. Its innovative treatments utilize water vapor technology, which employs energy from a small amount of water to effectively ablate cancerous tissue. This method not only targets the cancer but also aims to safeguard surrounding healthy structures, thereby minimizing the risk of significant side effects often associated with traditional cancer treatments.

InterShunt is a medical device company based in St. Louis, Missouri, founded in 2015. The company specializes in designing and developing a proprietary catheter-based system aimed at alleviating the symptoms of heart failure. Their innovative approach centers on left atrial decompression, utilizing a minimally invasive procedure that does not require any implants or energy for capturing and excising tissue from the interatrial septum. By enabling healthcare professionals to effectively reduce left atrial pressure, InterShunt seeks to provide significant relief for millions of individuals suffering from heart failure.

Knopp Biosciences LLC is a biotechnology company based in Pittsburgh, Pennsylvania, focused on discovering and developing innovative treatments for inflammatory and neurological diseases. Founded in 2004, the company is engaged in clinical programs targeting inflammation and hematology, including dexpramipexole, an anti-inflammatory therapeutic that modulates white blood cells. Additionally, Knopp has a hematology discovery program aimed at selectively arresting eosinophil maturation with orally available medications. The company also explores a KCNQ2 preclinical program, which seeks to activate a crucial ion channel in nerve cells, addressing conditions such as neonatal encephalopathy, epilepsy, and neuropathic pain. Furthermore, Knopp is developing small molecule modulators to enhance mitochondrial efficiency as part of its mitochondrial discovery program. Through its focused research and development efforts, Knopp Biosciences aims to provide breakthrough treatments that improve patient outcomes and address significant healthcare challenges.

BioStable is a cardiovascular device company that develops innovative new products for the treatment of cardiovascular diseases. The company is led by an experienced group of industry executives with expertise in rapid and effective medical device development. The organization incorporates core strengths in all areas of product development including quality systems, design, engineering, prototyping and pilot production, in-vitro and in-vivo testing, manufacturing, global regulatory relationships, clinical product validation, market launch, and distribution. BioStable provides a competitive edge by minimizing time to market for cost-effective medical devices that deliver improved clinical outcomes. The company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease. BioStable was founded in

AEGEA Medical is pioneering the application of its Adaptive Vapor Ablation technology to deliver therapies that provide high quality patient outcomes to a wider range of patients. AEGEA’s FDA approved water vapor technology enables the delivery of a safe and effective endometrial ablation for the treatment of menorrhagia in a simple, office-based procedure that takes only minutes. With a vision to expand safe and effective treatment options to more patients, and provide physicians with the confidence and convenience necessary to perform office-based procedures, AEGEA is inspiring new approaches to women’s healthcare. Founded in 2008, AEGEA Medical is located in in Menlo Park, California.

AEGEA Medical is pioneering the application of its Adaptive Vapor Ablation technology to deliver therapies that provide high quality patient outcomes to a wider range of patients. AEGEA’s FDA approved water vapor technology enables the delivery of a safe and effective endometrial ablation for the treatment of menorrhagia in a simple, office-based procedure that takes only minutes. With a vision to expand safe and effective treatment options to more patients, and provide physicians with the confidence and convenience necessary to perform office-based procedures, AEGEA is inspiring new approaches to women’s healthcare. Founded in 2008, AEGEA Medical is located in in Menlo Park, California.

ATFX is an online Forex and CFD broker regulated by the FCA, their goal is to provide their clients with the absolute trading experience. With their state-of-the-art client portal and world leading encryption systems, you can be sure your funds are safe. By implementing the latest bridging technologies, they obtain the best prices from their liquidity provider. Their payment systems are super-fast allowing speedy crediting and debiting of accounts. Opening an account is quick and checks are even quicker, meaning you’ll be ready to trade promptly. If you’re up and about, they’ve got your back! With their online mobile trading systems, you’ll be able to trade on the move and react instantly to moving markets, allowing you to maximize opportunities. ATFX is headquartered in the heart of London, offering FX CFD’s, Gold, Metals and commodities. Their expert team are readily available to answer any queries with a 24/5 service, meaning you’re never alone. The sleek client portal is easy to use and gives full account management with 24/5 support services.

PreTel is a Canadian company specializing in the development of fetal monitoring systems aimed at enhancing maternal and pediatric outcomes during labor and delivery. The company focuses on uterine electromyography (uEMG) monitoring and area sensor solutions, which address the challenges of accurately distinguishing between true and false labor. This innovation helps reduce unnecessary invasive monitoring, cesarean deliveries, and costly neonatal intensive care stays. PreTel's sensors are designed to assess all stages of pregnancy by identifying independent contraction activity in different regions of the uterus. This capability allows healthcare providers to manage preterm labor more effectively and ensure safer delivery processes, ultimately improving care for both mothers and newborns.

Arrivo BioVentures LLC is a biopharmaceutical company based in Morrisville, North Carolina, that specializes in the development of biologics and small molecules aimed at enhancing patient outcomes. Founded in 2015, the company focuses on drug development, leveraging its expertise to create reformulated products, new chemical entities, and biologics. Arrivo BioVentures emphasizes the importance of collaboration with regulatory bodies, such as the FDA, to streamline the approval process and efficiently execute clinical programs. By proactively engaging with regulators, the company seeks to minimize unexpected challenges and accelerate the implementation of its development programs.

ATFX is an online Forex and CFD broker regulated by the FCA, their goal is to provide their clients with the absolute trading experience. With their state-of-the-art client portal and world leading encryption systems, you can be sure your funds are safe. By implementing the latest bridging technologies, they obtain the best prices from their liquidity provider. Their payment systems are super-fast allowing speedy crediting and debiting of accounts. Opening an account is quick and checks are even quicker, meaning you’ll be ready to trade promptly. If you’re up and about, they’ve got your back! With their online mobile trading systems, you’ll be able to trade on the move and react instantly to moving markets, allowing you to maximize opportunities. ATFX is headquartered in the heart of London, offering FX CFD’s, Gold, Metals and commodities. Their expert team are readily available to answer any queries with a 24/5 service, meaning you’re never alone. The sleek client portal is easy to use and gives full account management with 24/5 support services.

PreTel is a Canadian company specializing in the development of fetal monitoring systems aimed at enhancing maternal and pediatric outcomes during labor and delivery. The company focuses on uterine electromyography (uEMG) monitoring and area sensor solutions, which address the challenges of accurately distinguishing between true and false labor. This innovation helps reduce unnecessary invasive monitoring, cesarean deliveries, and costly neonatal intensive care stays. PreTel's sensors are designed to assess all stages of pregnancy by identifying independent contraction activity in different regions of the uterus. This capability allows healthcare providers to manage preterm labor more effectively and ensure safer delivery processes, ultimately improving care for both mothers and newborns.

AEGEA Medical is pioneering the application of its Adaptive Vapor Ablation technology to deliver therapies that provide high quality patient outcomes to a wider range of patients. AEGEA’s FDA approved water vapor technology enables the delivery of a safe and effective endometrial ablation for the treatment of menorrhagia in a simple, office-based procedure that takes only minutes. With a vision to expand safe and effective treatment options to more patients, and provide physicians with the confidence and convenience necessary to perform office-based procedures, AEGEA is inspiring new approaches to women’s healthcare. Founded in 2008, AEGEA Medical is located in in Menlo Park, California.